Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist JNJ‐64565111 in individuals with type 2 diabetes mellitus and obesity: A randomized dose‐ranging study... von Di Prospero, Nicholas A., Yee, Jaqueline, Frustaci, Mary E., Samtani, Mahesh N., Alba, Maria, Fleck, Penny

Volltext

Coadministration of Canagliflozin and Phentermine for Weight Management in Overweight and Obese Individuals Without Diabetes: A Randomized Clinical Trial von Hollander, Priscilla, Bays, Harold E, Rosenstock, Julio, Frustaci, Mary Ellen, Fung, Albert, Vercruysse, Frank, Erondu, Ngozi

Volltext

Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study von Sandborn, William J., D’Haens, Geert R., Reinisch, Walter, Panés, Julián, Chan, Daphne, Gonzalez, Susana, Weisel, Kathleen, Germinaro, Matthew, Frustaci, Mary Ellen, Yang, Zijiang, Adedokun, Omoniyi J., Han, Chenglong, Panaccione, Remo, Hisamatsu, Tadakazu, Danese, Silvio, Rubin, David T., Sands, Bruce E., Afzali, Anita, Andrews, Jane M., Feagan, Brian G.

Volltext

EFFICACY AND SAFETY OF GUSELKUMAB THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS OF THE GALAXI 2 & 3 PHASE 3 STUDIES von Panaccione, Remo, Danese, Silvio, Feagan, Brian G., D’Haens, Geert, Afzali, Anita, Reinisch, Walter, Panés, Julián, Rubin, David T., Andrews, Jane M., Hisamatsu, Tadakazu, Terry, Natalie A., Salese, Leonardo, Van Rampelbergh, Rian, Frustaci, Mary Ellen S., Yang, Zijiang, Johanns, Jewel, Wan, Kitty Y., Yee, Jacqueline, Sands, Bruce E.

Volltext

888: EFFICACY AND SAFETY OF GUSELKUMAB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: WEEK 48 ANALYSES FROM THE PHASE 2 GALAXI 1 STUDY von Panaccione, Remo, Rubin, David T., Sands, Bruce E., Reinisch, Walter, D'Haens, Geert, Panés, Julian, Gonzalez, Susana, Weisel, Kathleen, Sahoo, Aparna, Frustaci, Mary Ellen S., Yang, Zijiang, Sandborn, William J., Afzali, Anita, Hisamatsu, Tadakazu, Danese, Silvio, Andrews, Jane M., Feagan, Brian G.

Volltext

Fr532 THE EFFECT OF GUSELKUMAB INDUCTION THERAPY ON INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: WEEK 12 RESULTS FROM THE PHASE 2 GALAXI... von Sands, Bruce E., Danese, Silvio, Andrews, Jane M., Weisel, Kathleen, Chan, Daphne, Johanns, Jewel, Frustaci, Mary Ellen S., Yang, Zijiang, Cunningham, Melissa, Ghanem, Louis, Panaccione, Remo, Afzali, Anita, Sandborn, William J.

Volltext

A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis von Mayorga, Arthur J., Flores, Christopher M., Trudeau, Jeremiah J., Moyer, John A., Shalayda, Kevin, Dale, Mark, Frustaci, Mary Ellen, Katz, Nathaniel, Manitpisitkul, Prasarn, Treister, Roi, Ratcliffe, Stuart, Romano, Gary

Volltext